Dr. George Poste, Senior Technical Advisor
 
Dr. Poste is Director of The Biodesign Institute at Arizona State University (http://www.biodesign.asu.edu/). This is a major new initiative combining research groups in biotechnology, nanotechnology, materials science, advanced computing and neuromorphic engineering. In addition to his academic post he serves as Chairman of Orchid Cellmark, the leading company in DNA forensic analysis, and serves on the Board of Directors of Monsanto, Exelixis and the Molecular Profiling Institute. From 1992 to 1999 he was Chief Science and Technology Officer and President, R&D of SmithKline Beecham (SB). During his tenure at SB he was associated with the successful registration of 31 drug, vaccine and diagnostic products. He has published over 350 scientific papers and co-edited 14 books on cancer, drug delivery and health policy. He has received honorary degrees in Science and Law for his research contributions and was awarded the rank of Commander of the British Empire by HM Queen Elizabeth II for his services to international health. In 2004 he was named as ‘R&D Scientist of the Year’ by R&D Magazine.

He is a Board Certified Pathologist, a Fellow of the Royal Society, and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University and a member of the Council for Foreign Relations. He is a member of the Defense Science Board of the US Department of Defense and has served a number of National Academy panels related to national security. He also serves as a member of the Forum on Microbial Threats of the Institute of Medicine Board on Global Health.